A
Amir H. Davarpanah
Researcher at Emory University
Publications - 58
Citations - 1243
Amir H. Davarpanah is an academic researcher from Emory University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 50 publications receiving 994 citations. Previous affiliations of Amir H. Davarpanah include Northwestern University & Emory University Hospital.
Papers
More filters
Journal ArticleDOI
ACR Appropriateness Criteria ® imaging of mesenteric ischemia.
Isabel B. Oliva,Amir H. Davarpanah,Frank J. Rybicki,Benoit Desjardins,Scott D. Flamm,Christopher J. François,Marie Gerhard-Herman,Sanjeeva P. Kalva,M. Ashraf Mansour,Emile R. Mohler,Emile R. Mohler,Matthew P. Schenker,Clifford R. Weiss,Karin E. Dill +13 more
TL;DR: This document evaluates and rates the appropriateness of imaging to evaluate patients with clinically suspected mesenteric ischemia and catheter-based angiography is considered the reference standard and enables diagnosis and treatment.
Journal ArticleDOI
Evaluation of Peripheral Arterial Disease with Nonenhanced Quiescent-Interval Single-Shot MR Angiography
Philip A. Hodnett,Ioannis Koktzoglou,Amir H. Davarpanah,Timothy G. Scanlon,Jeremy D. Collins,John Sheehan,Eugene Dunkle,NavYash Gupta,James C. Carr,Robert R. Edelman +9 more
TL;DR: QISS nonenhanced MR angiography offers an alternative to currently used imaging tests for symptomatic chronic lower limb ischemia, for which the administration of iodinated or gadolinium-based contrast agents is contraindicated.
Journal ArticleDOI
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
Anahita Sadeghi,Ali Ali Asgari,Alireza Norouzi,Zahedin Kheiri,Amir Anushirvani,Mahnaz Montazeri,Hadiseh Hosamirudsai,Shirin Afhami,Elham Akbarpour,Rasoul Aliannejad,Amir Reza Radmard,Amir H. Davarpanah,Jacob Levi,Hannah Wentzel,Ambar Qavi,Anna Garratt,Bryony Simmons,Andrew Hill,Shahin Merat +18 more
TL;DR: The addition of sofosbuvir and daclatasvir to standard care significantly reduced the duration of hospital stay compared with standard care alone and although fewer deaths were observed in the treatment arm, this was not statistically significant.
Journal ArticleDOI
Radiologic management of COVID-19: Preliminary experience of the iranian society of radiology COVID-19 consultant group (ISRCC)
Arash Mahdavi,Nastaran Khalili,Amir H. Davarpanah,Taraneh Faghihi,Ali Mahdavi,Sara Haseli,Ali Sabri,Shahram Kahkouee,Mohammad Ali Kazemi,Payam Mehrian,Farahnaz Falahati,Mehrdad Bakhshayeshkaram,Morteza Sanei Taheri +12 more
Journal ArticleDOI
Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service.
Amir H. Davarpanah,Arash Mahdavi,Ali Sabri,Taraneh Faghihi Langroudi,Shahram Kahkouee,Sara Haseli,Mohammad Ali Kazemi,Payam Mehrian,Ali Mahdavi,Farahnaz Falahati,Abuzar Moradi Tuchayi,Mehrdad Bakhshayeshkaram,Morteza Sanei Taheri +12 more